Log In
Print this Print this

KI 1003

  Manage Alerts
Collapse Summary General Information
Company Kuhnil Pharmaceutical Co. Ltd.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationAddiction
Indication DetailsTreat eating disorder
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today